These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 24519609)

  • 1. A novel IFITM5 mutation in severe atypical osteogenesis imperfecta type VI impairs osteoblast production of pigment epithelium-derived factor.
    Farber CR; Reich A; Barnes AM; Becerra P; Rauch F; Cabral WA; Bae A; Quinlan A; Glorieux FH; Clemens TL; Marini JC
    J Bone Miner Res; 2014 Jun; 29(6):1402-11. PubMed ID: 24519609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations of bone material properties in growing Ifitm5/BRIL p.S42 knock-in mice, a new model for atypical type VI osteogenesis imperfecta.
    Hedjazi G; Guterman-Ram G; Blouin S; Schemenz V; Wagermaier W; Fratzl P; Hartmann MA; Zwerina J; Fratzl-Zelman N; Marini JC
    Bone; 2022 Sep; 162():116451. PubMed ID: 35654352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Type V OI primary osteoblasts display increased mineralization despite decreased COL1A1 expression.
    Reich A; Bae AS; Barnes AM; Cabral WA; Hinek A; Stimec J; Hill SC; Chitayat D; Marini JC
    J Clin Endocrinol Metab; 2015 Feb; 100(2):E325-32. PubMed ID: 25387264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extremely low level of serum pigment epithelium-derived factor is a special biomarker of Chinese osteogenesis imperfecta patients with SERPINF1 mutations.
    Wang JY; Li LJ; Zhang Q; Liu Y; Lv F; Xu XJ; Song YW; Wang O; Jiang Y; Xia WB; Xing XP; Li M
    Clin Chim Acta; 2018 Mar; 478():216-221. PubMed ID: 29104038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antagonism Between PEDF and TGF-β Contributes to Type VI Osteogenesis Imperfecta Bone and Vascular Pathogenesis.
    Kang H; Aryal Ac S; Barnes AM; Martin A; David V; Crawford SE; Marini JC
    J Bone Miner Res; 2022 May; 37(5):925-937. PubMed ID: 35258129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exome sequencing identifies truncating mutations in human SERPINF1 in autosomal-recessive osteogenesis imperfecta.
    Becker J; Semler O; Gilissen C; Li Y; Bolz HJ; Giunta C; Bergmann C; Rohrbach M; Koerber F; Zimmermann K; de Vries P; Wirth B; Schoenau E; Wollnik B; Veltman JA; Hoischen A; Netzer C
    Am J Hum Genet; 2011 Mar; 88(3):362-71. PubMed ID: 21353196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Restoration of the serum level of SERPINF1 does not correct the bone phenotype in Serpinf1 null mice.
    Rajagopal A; Homan EP; Joeng KS; Suzuki M; Bertin T; Cela R; Munivez E; Dawson B; Jiang MM; Gannon F; Crawford S; Lee BH
    Mol Genet Metab; 2016 Mar; 117(3):378-82. PubMed ID: 26693895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pigment epithelium-derived factor restoration increases bone mass and improves bone plasticity in a model of osteogenesis imperfecta type VI via Wnt3a blockade.
    Belinsky GS; Sreekumar B; Andrejecsk JW; Saltzman WM; Gong J; Herzog RI; Lin S; Horsley V; Carpenter TO; Chung C
    FASEB J; 2016 Aug; 30(8):2837-48. PubMed ID: 27127101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel Mutations in SERPINF1 Result in Rare Osteogenesis Imperfecta Type VI.
    Wang JY; Liu Y; Song LJ; Lv F; Xu XJ; San A; Wang J; Yang HM; Yang ZY; Jiang Y; Wang O; Xia WB; Xing XP; Li M
    Calcif Tissue Int; 2017 Jan; 100(1):55-66. PubMed ID: 27796462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of SERPINF1 in-frame mutations in osteogenesis imperfecta type VI.
    Al-Jallad H; Palomo T; Roughley P; Glorieux FH; McKee MD; Moffatt P; Rauch F
    Bone; 2015 Jul; 76():115-20. PubMed ID: 25868797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Osteogenesis Imperfecta Type V Mutant BRIL/IFITM5 Promotes Transcriptional Activation of MEF2, NFATc, and NR4A in Osteoblasts.
    Maranda V; Gaumond MH; Moffatt P
    Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A mutation in the 5'-UTR of IFITM5 creates an in-frame start codon and causes autosomal-dominant osteogenesis imperfecta type V with hyperplastic callus.
    Semler O; Garbes L; Keupp K; Swan D; Zimmermann K; Becker J; Iden S; Wirth B; Eysel P; Koerber F; Schoenau E; Bohlander SK; Wollnik B; Netzer C
    Am J Hum Genet; 2012 Aug; 91(2):349-57. PubMed ID: 22863195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of expression of SERPINF1, the gene coding for pigment epithelium-derived factor, causes progressively deforming osteogenesis imperfecta with normal type I collagen.
    Venturi G; Gandini A; Monti E; Dalle Carbonare L; Corradi M; Vincenzi M; Valenti MT; Valli M; Pelilli E; Boner A; Mottes M; Antoniazzi F
    J Bone Miner Res; 2012 Mar; 27(3):723-8. PubMed ID: 22113968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topological mapping of BRIL reveals a type II orientation and effects of osteogenesis imperfecta mutations on its cellular destination.
    Patoine A; Gaumond MH; Jaiswal PK; Fassier F; Rauch F; Moffatt P
    J Bone Miner Res; 2014 Sep; 29(9):2004-16. PubMed ID: 24715519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Osteogenesis imperfecta without features of type V caused by a mutation in the IFITM5 gene.
    Grover M; Campeau PM; Lietman CD; Lu JT; Gibbs RA; Schlesinger AE; Lee BH
    J Bone Miner Res; 2013 Nov; 28(11):2333-7. PubMed ID: 23674381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A co-occurrence of osteogenesis imperfecta type VI and cystinosis.
    Tucker T; Nelson T; Sirrs S; Roughley P; Glorieux FH; Moffatt P; Schlade-Bartusiak K; Brown L; Rauch F
    Am J Med Genet A; 2012 Jun; 158A(6):1422-6. PubMed ID: 22528245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A mouse model for human osteogenesis imperfecta type VI.
    Bogan R; Riddle RC; Li Z; Kumar S; Nandal A; Faugere MC; Boskey A; Crawford SE; Clemens TL
    J Bone Miner Res; 2013 Jul; 28(7):1531-6. PubMed ID: 23413146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of circulating pigment epithelium-derived factor is a marker of osteogenesis imperfecta type VI.
    Rauch F; Husseini A; Roughley P; Glorieux FH; Moffatt P
    J Clin Endocrinol Metab; 2012 Aug; 97(8):E1550-6. PubMed ID: 22669302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel mutations of the SERPINF1 and FKBP10 genes in Chinese families with autosomal recessive osteogenesis imperfecta.
    Zhang H; Xu Y; Yue H; Wang C; Gu J; He J; Fu W; Hu W; Zhang Z
    Int J Mol Med; 2018 Jun; 41(6):3662-3670. PubMed ID: 29512769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crispr-Cas9 engineered osteogenesis imperfecta type V leads to severe skeletal deformities and perinatal lethality in mice.
    Rauch F; Geng Y; Lamplugh L; Hekmatnejad B; Gaumond MH; Penney J; Yamanaka Y; Moffatt P
    Bone; 2018 Feb; 107():131-142. PubMed ID: 29174564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.